Clinical Trials
3 trialsNCT00573989 2019-01-03
Intensity-Modulated Radiation Therapy, Pemetrexed, and Erlotinib in Treating Patients With Recurrent or Second Primary Head and Neck Cancer
Wake Forest University Health Sciences
Phase 1/2 Terminated
NCT00589667 2014-04-02
A Phase II Study of Pemetrexed Plus Gemcitabine for Metastatic/Recurrent Head and Neck Cancer (HNSCC)
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00503997 2012-05-10
Pemetrexed and Oxaliplatin in Treating Patients With Locally Advanced Head and Neck Cancer
Vanderbilt-Ingram Cancer Center
Phase 2 Completed